INS and Insulin resistance: Notably, akin to the sole previous CLA trial involving children, this investigation revealed no significant alterations in fasting glucose, insulin levels, or insulin resistance, suggesting that CLA exerted no adverse effects on these metabolic parameters within this cohort (Racine et al. 2010).